SURVANTA Side Effects

6747449-X | Bradycardia, Cardiac Arrest, Haemorrhage Intracranial, Lung Disorder
on May 24, 2010 Male patient from INDIA , weighting 4.41 lb, was treated with Survanta (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac arrest (What is cardiac arrest?), haemorrhage intracranial, lung disorder. Survanta dosage: Not Reported. Patient was hospitalized.

6295329-9 | Acute Respiratory Distress Syndrome, Sclerema, Sepsis
Patient was taking Survanta (View Usage). Patient had the following side effects: acute respiratory distress syndrome, sclerema, sepsis (What is sepsis?) on Jul 30, 2009 from INDIA Additional patient health information: Female patient , weighting 2.20 lb, was diagnosed with acute respiratory distress syndrome and. Survanta dosage: 2 Doses Of 4 Ml Administered From One Vial At 8 Hrs Of Life.. During the same period patient was treated with CLAVULANATE POTASSIUM (Not Reported) (View Clavulanate Potassium Review and Clavulanate Potassium Label ), AMOXICILLIN (Not Reported) (View Amoxicillin Review and Amoxicillin Label ), AMIKACIN (Not Reported) (View Amikacin Review and Amikacin Label ), DOBUTAMINE HCL (Not Reported) (View Dobutamine Hcl Review and Dobutamine Hcl Label ), DOPAMINE HCL (Not Reported) (View Dopamine Hcl Review and Dopamine Hcl Label ).

6295327-5 | Acute Respiratory Distress Syndrome, Sclerema, Sepsis
Adverse event was reported on Jul 31, 2009 by a Male patient taking Survanta (View Usage) (Dosage: A Single Dose Of 6 Ml Was Administered.) was diagnosed with acute respiratory distress syndrome and. Location: INDIA , weighting 3.33 lb, After Survanta was administered, patient had the following side effects: acute respiratory distress syndrome, sclerema, sepsis (What is sepsis?). During the same period patient was treated with CLAVULANATE POTASSIUM (Not Reported) (View Clavulanate Potassium Review and Clavulanate Potassium Label ), AMOXICILLIN (Not Reported) (View Amoxicillin Review and Amoxicillin Label ), AMIKACIN (Not Reported) (View Amikacin Review and Amikacin Label ), DOPAMINE HCL (Not Reported) (View Dopamine Hcl Review and Dopamine Hcl Label ), DOBUTAMINE HCL (Not Reported) (View Dobutamine Hcl Review and Dobutamine Hcl Label ).

6293062-0 | Cardiac Arrest, Central Venous Catheterisation, Ecchymosis, Fluid Replacement, Haematoma, Neonatal Respiratory Distress Syndrome, Traumatic Delivery
on Jul 27, 2009 Male patient from ECUADOR , weighting 1.32 lb, was diagnosed with neonatal respiratory distress syndrome and was treated with Survanta (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), central venous catheterisation, ecchymosis, fluid replacement, haematoma, neonatal respiratory distress syndrome, traumatic delivery. Survanta dosage: 2.4 Ml Repeated After 8 Hours Given Intratracheal Other = Per Endotracheal Tube. Patient was hospitalized.


6286197-X | Acute Respiratory Distress Syndrome, Sclerema, Sepsis
on Jul 24, 2009 Female patient from INDIA , weighting 2.20 lb, was diagnosed with acute respiratory distress syndrome and was treated with Survanta (View Usage). Patient had the following side effects: acute respiratory distress syndrome, sclerema, sepsis (What is sepsis?). Survanta dosage: 2 Doses Of 4 Ml Administered From One Vial At 8 Hrs Of Life..

6286167-1 | Acute Respiratory Distress Syndrome, Sclerema, Sepsis
Patient was taking Survanta (View Usage). After Survanta was administered, patient had the following side effects: acute respiratory distress syndrome, sclerema, sepsis (What is sepsis?) on Jul 24, 2009 from INDIA Additional patient health information: Male patient , weighting 3.33 lb, was diagnosed with acute respiratory distress syndrome and. Survanta dosage: A Single Dose Of 6 Ml Was Administered..

6279415-5 | Acute Respiratory Distress Syndrome, Sclerema, Sepsis
Adverse event was reported on Jul 20, 2009 by a Female patient taking Survanta (View Usage) (Dosage: 2 Doses Administered From One Vial At 8 Hrs Of Life) was diagnosed with acute respiratory distress syndrome and. Location: INDIA , weighting 2.20 lb, Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, sclerema, sepsis (What is sepsis?).

6279413-1 | Acute Respiratory Distress Syndrome, Sclerema, Sepsis
on Jul 20, 2009 Male patient from INDIA , weighting 3.33 lb, was diagnosed with acute respiratory distress syndrome and was treated with Survanta (View Usage). Patient had the following side effects: acute respiratory distress syndrome, sclerema, sepsis (What is sepsis?). Survanta dosage: .

5868174-3 | Pulmonary Haemorrhage
on Aug 22, 2008 Female patient from BRAZIL , weighting 1.41 lb, was treated with Survanta (View Usage). After Survanta was administered, patient had the following side effects: pulmonary haemorrhage. Survanta dosage: 100mg/kg.

5675231-3 | Bradycardia, Cardiac Arrest, Congenital Pneumonia, Hypotonia, Respiratory Distress
Patient was taking Survanta (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac arrest (What is cardiac arrest?), congenital pneumonia, hypotonia, respiratory distress on Mar 10, 2008 from LIBYAN ARAB JAMAHIRIYA Additional patient health information: Male patient , weighting 12.68 lb, was diagnosed with respiratory distress and. Survanta dosage: 4 Ml/kg. Patient was hospitalized.

5646597-5 | Bradycardia, Cardiac Arrest, Congenital Pneumonia, Hypotonia, Respiratory Distress
Adverse event was reported on Feb 20, 2008 by a Male patient taking Survanta (View Usage) (Dosage: 4 Ml/kg) was diagnosed with respiratory distress and. Location: LIBYAN ARAB JAMAHIRIYA , weighting 12.68 lb, Patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), congenital pneumonia, hypotonia, respiratory distress. Patient was hospitalized.

5641681-4 | Blood Glucose Increased, Bradycardia, Septic Shock
on Feb 18, 2008 Female patient from LIBYAN ARAB JAMAHIRIYA , weighting 1.98 lb, was treated with Survanta (View Usage). After Survanta was administered, patient had the following side effects: blood glucose increased, bradycardia, septic shock. Survanta dosage: 4ml/kg Not Less Than 6 Hours. Patient was hospitalized.

5611394-3 | Apnoea, Bradycardia, Dyspnoea, Hypotonia, Placental Transfusion Syndrome
on Jan 23, 2008 Female patient from LIBYAN ARAB JAMAHIRIYA , weighting 2.56 lb, was diagnosed with neonatal respiratory distress syndrome, prophylaxis and was treated with Survanta (View Usage). Patient experienced the following unwanted or unexpected effects: apnoea, bradycardia, dyspnoea, hypotonia, placental transfusion syndrome. Survanta dosage: Unit Dose = 4ml/kg Not Less Than 6 Hours.. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

5598598-3 | Apnoea, Bradycardia, Dyspnoea, Hypotonia, Placental Transfusion Syndrome
Patient was taking Survanta (View Usage). Patient had the following side effects: apnoea, bradycardia, dyspnoea, hypotonia, placental transfusion syndrome on Jan 12, 2008 from LIBYAN ARAB JAMAHIRIYA Additional patient health information: Female patient , weighting 2.56 lb, was diagnosed with neonatal respiratory distress syndrome, prophylaxis and. Survanta dosage: Unit Dose = 4ml/kg Not Less Than 6 Hours.. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

4744615-X | Neonatal Multi-organ Failure, Neonatal Respiratory Distress Syndrome, Sepsis Neonatal
Adverse event was reported on Aug 06, 2004 by a Male patient taking Survanta (View Usage) (Dosage: ) was diagnosed with respiratory distress and. Location: UNITED STATES , weighting 1.65 lb, After Survanta was administered, patient had the following side effects: neonatal multi-organ failure, neonatal respiratory distress syndrome, sepsis neonatal. Patient was hospitalized.

4744614-8 | Neonatal Respiratory Failure, Sepsis
on Aug 06, 2004 Female patient from UNITED STATES , weighting 1.38 lb, was diagnosed with respiratory distress and was treated with Survanta (View Usage). Patient experienced the following unwanted or unexpected effects: neonatal respiratory failure, sepsis (What is sepsis?). Survanta dosage: . During the same period patient was treated with AMPICILLIN (AMPICILLIN) (AMPICILLIN) (View Ampicillin (ampicillin) (ampicillin) Review and Ampicillin (ampicillin) (ampicillin) Label ), GENTAMICIN SULFATE (GENTAMICIN SULFATE)(GENTAMICIN SULFATE) (View Gentamicin Sulfate (gentamicin Sulfate)(gentamicin Sulfate) Review and Gentamicin Sulfate (gentamicin Sulfate)(gentamicin Sulfate) Label ), FENTANYL CITRATE (FENTANYL CITRATE) (FENTANYL CITRATE) (View Fentanyl Citrate (fentanyl Citrate) (fentanyl Citrate) Review and Fentanyl Citrate (fentanyl Citrate) (fentanyl Citrate) Label ), MIDAZOLAM HYDROCHLORIDE (MIDAZOLAM HYDROCHLORIDE) (MIDAZOLAM HYDROCHLO (View Midazolam Hydrochloride (midazolam Hydrochloride) (midazolam Hydrochlo Review and Midazolam Hydrochloride (midazolam Hydrochloride) (midazolam Hydrochlo Label ), GLUCOSE (View Glucose Review and Glucose Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ).

4744613-6 | Neonatal Respiratory Failure, Pneumothorax, Pulmonary Interstitial Emphysema Syndrome
on Jan 14, 2005 Female patient from UNITED STATES , weighting 2.26 lb, was diagnosed with respiratory distress and was treated with Survanta (View Usage). Patient had the following side effects: neonatal respiratory failure, pneumothorax, pulmonary interstitial emphysema syndrome. Survanta dosage: . During the same period patient was treated with SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), NITRIC OXIDE (View Nitric Oxide Review and Nitric Oxide Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ). Patient was hospitalized.

4744612-4 | Heart Rate Decreased, Pneumothorax, Sepsis Neonatal
Patient was taking Survanta (View Usage). After Survanta was administered, patient had the following side effects: heart rate decreased, pneumothorax, sepsis neonatal on Aug 06, 2004 from UNITED STATES Additional patient health information: Female patient , weighting 1.23 lb, was diagnosed with respiratory distress and. Survanta dosage: . During the same period patient was treated with EPINEPHRINE (View Epinephrine Review and Epinephrine Label ).

4744611-2 | Pneumothorax
Adverse event was reported on Aug 06, 2004 by a Female patient taking Survanta (View Usage) (Dosage: ) was diagnosed with respiratory distress and. Location: UNITED STATES , weighting 0.98 lb, Patient experienced the following unwanted or unexpected effects: pneumothorax.

4744610-0 | Intraventricular Haemorrhage Neonatal, Pneumothorax, Pulmonary Haemorrhage
on Aug 06, 2004 Male patient from UNITED STATES , weighting 1.88 lb, was diagnosed with respiratory distress and was treated with Survanta (View Usage). Patient had the following side effects: intraventricular haemorrhage neonatal, pneumothorax, pulmonary haemorrhage. Survanta dosage: . During the same period patient was treated with PHENOBARBITAL SODIUM 100MG CAP (View Phenobarbital Sodium 100mg Cap Review and Phenobarbital Sodium 100mg Cap Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ). Patient was hospitalized.

4735880-3 | Bradyarrhythmia, Convulsion, Hypotension, Respiratory Distress, Thrombocytopenia
on Aug 04, 2005 Male patient from UNITED STATES , weighting 6.53 lb, was diagnosed with acute respiratory distress syndrome and was treated with Survanta (View Usage). After Survanta was administered, patient had the following side effects: bradyarrhythmia, convulsion, hypotension, respiratory distress, thrombocytopenia. Survanta dosage: 12ml Et Tube. During the same period patient was treated with AMPICILLIN (View Ampicillin Review and Ampicillin Label ), CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), VANOMYCIN (View Vanomycin Review and Vanomycin Label ), MORPHINE (View Morphine Review and Morphine Label ).